Videos

Robert J. Hopkin, MD, clinical geneticist, Cincinnati Children's Hospital Medical Center, addresses major unmet needs in Fabry disease, ranging from uncontrolled pain to irreversible damage prior to treatment initiation.

Dr Robert Hopkin on Unmet Needs in Fabry Disease

Victoria Ly, MD, MPH, outlines one method of tackling vision screening follow-up rate disparities among children in Arkansas. 



Dr Victoria Ly Offers Potential Solutions to Vision Screening Follow-up Disparities 

Adriaan Voors, MD, discusses possible mechanisms of action of empagliflozin that produce such beneficial results among patients with heart failure, in an interview about the EMPULSE trial prior to this year’s American Heart Association Scientific Sessions.

Dr Adriaan Voors Explains Potential Decongestive Benefits of Empagliflozin

Kimberly Westrich, MA, vice president of health services research at the National Pharmaceutical Council, discusses the shift to a value-based system from a fee-for-service one and how the health care system can incentivize high-value care.

Kimberly Westrich on Incentivizing Value-Based Care in Benefit Design and Reimbursement Strategies

Judith Lavrich, MD, and Jordan Hamburger discuss what additional studies need to be carried out in order to better understand the effects of virtual learning on children's long-term eye health. 

Researchers: More Studies Needed on Long-term Impact of Virtual Learning on Children's Eye Health

Ian J. Neeland, MD, FACC, FAHA, is co-director of the Center for Integrated and Novel Approaches in Vascular-Metabolic Disease for University Hospitals Harrington Heart & Vascular Institute and director of the UH Center for Cardiovascular Prevention, in the Cleveland, Ohio, area. Here, he explains how sodium-glucose co-transporter 2 (SGLT2) inhibitors can treat metabolic physiologic effects of sleep apnea.

Dr Ian Neeland Describes Physiologic Effects of SGLT2 Inhibitors on Sleep Apnea

Robert J. Hopkin, MD, clinical geneticist, Cincinnati Children's Hospital Medical Center, details various known and understudied health-related quality-of-life factors in patients with Fabry disease.

Dr Robert Hopkin Addresses HRQOL Factors in Fabry Disease

It’s right to acknowledge that dental, hearing, and vision are important for total health care for Medicare beneficiaries, said Melissa Andel, MPP, vice president of health policy at CommonHealth Solutions.

Melissa Andel on Adding Dental, Hearing, Vision Benefits to Medicare

The high cost of specialty drugs makes it important to use companion diagnostics and other tests to make sure the drug is going to the right patient, said George Van Antwerp, MBA, managing director, Deloitte Consulting.

George Van Antwerp: Specialty Drugs Rely on Personalization for Optimal Outcomes

Will Nutland, DrPH, is cofounder of PrEPster, an honorary assistant professor at the London School of Hygiene and Tropical Medicine, and an activist. 

Interviews